Studies have shown that the scientific basis of ACE inhibitors angiotensin II is effective in patients with IgA nephropathy with a proteinuria <1 g / 24h for improving renal function and proteinuria, as well as corticosteroid therapy for 6 months in IgA nephropathy patients with proteinuria ≥ 1 g / 24h for improved kidney function and proteinuria.